Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Ofloxacin

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05946655Not ApplicableCompleted

Diagnostics of Chronic Endometritis in Infertility

NCT05590104Not ApplicableUnknown

Hysteroscopic Isthmocele Repair on IVF Outcome

NCT02720887CompletedPrimary

Presence of Nanoparticles in the Amniotic Fluid

Showing all 3 trials

Research Network

Common Treatments

  • Ofloxacin1
  • Ofloxacin Metronidazole1
  • Nanoparticles Load1
  • Hysteroscopic Cs Scar Defect Repair1
  • Metronidazole1

Active Sponsors

  • SAINBIOSE1
  • Jagiellonian University1
  • Centre Hospitalier Universitaire de Saint Etienne1
  • HealthPlus Fertility Center1

Top Investigators

Related Conditions

  • Cesarean Section Dehiscence1
  • Infertility Unexplained1
  • Reproductive Issues1
  • Abnormal Uterine Bleeding1

Activity Timeline